John Josey

John Josey is currently a Venture Partner at The Column Group in Dallas, Texas, with a background that includes serving as President and Chief Executive Officer at Peloton Therapeutics, Inc., and Vice President of Discovery Chemistry at Array BioPharma. He has made significant contributions to the biotech and healthcare sectors, investing in companies like Atavistik Bio. John Josey's career highlights include holding leadership roles at prominent companies in the biotech industry, such as Peloton Therapeutics, Inc., and Array BioPharma, and his current role as a Venture Partner at The Column Group, where he continues to make impactful investments in the healthcare sector.